Gregory Fraser
Stock Analyst at Truist Securities
(2.68)
# 2,132
Out of 5,090 analysts
39
Total ratings
55.56%
Success rate
16.93%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $81.77 | +10.06% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $169.70 | +20.80% | 2 | Aug 28, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $6.93 | +1.01% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $1.15 | +13,813.04% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.55 | +252.94% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $12.18 | -42.53% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $86.11 | -66.32% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $12.11 | +684.48% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $6.85 | +162.77% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $31.20 | +28.21% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $81.77
Upside: +10.06%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $169.70
Upside: +20.80%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $6.93
Upside: +1.01%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $1.15
Upside: +13,813.04%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.55
Upside: +252.94%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $12.18
Upside: -42.53%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $86.11
Upside: -66.32%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $12.11
Upside: +684.48%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $6.85
Upside: +162.77%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $31.20
Upside: +28.21%